A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...
“How I Knew I Had Ovarian Cancer”: A Patient’s Story Reveals an Unexpected Benefit of Daily Exercise
A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...
Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis.
Researchers examined CA-125 levels at diagnosis, defining them as elevated/borderline or negative/normal in 250,749 patients ...
The Associated Press on MSN12d
Blood test for ovarian cancer misses some Black and Native American patients, study findsFinding ovarian cancer early can lead to better chances of survival. The new study, supported by grants from the National ...
Health and Me on MSN5d
Ovarian Cancer Test May Be Less Effective For Black And Native American PatientsOvarian cancer is the fifth leading cause of cancer-related deaths among women in the U.S. However, the racial bias makes it ...
Mural Oncology said that it won't continue developing its ovarian cancer drug candidate Nemvaleukin to be used in conjunction with Merck's Keytruda after results showed no statistical improvement in ...
The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American ...
The researchers analyzed data from more than 200,000 women with ovarian cancer from 2004 through 2020 who’d had a CA-125 blood test. Black and Native American patients were 23% less likely to ...
The researchers analyzed data from more than 200,000 women with ovarian cancer from 2004 through 2020 who’d had a CA-125 blood test. Black and Native American patients were 23% less likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results